Celgene Corporation to Announce Second Quarter 2017 Results on July 27, 2017


The webcast can be accessed from the Investor Relations page at www.celgene.com . Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.



from Biotech News